SHA:688670 Revenue

In the year 2025, Jiangsu Gdk Biological Technology had annual revenue of 113.23M CNY with 40.13% growth. Jiangsu Gdk Biological Technology had revenue of 38.57M in the quarter ending December 31, 2025, a decrease of -7.95%.

Revenue

113.23M

Revenue Growth

+40.13%

P/S Ratio

20.89

Revenue / Employee

250.51K

Employees

449

Market Cap

2.37B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	113.23M	32.43M	40.13%
Dec 31, 2024	80.80M	-53.79M	-39.96%
Dec 31, 2023	134.59M	-183.89M	-57.74%
Dec 31, 2022	318.49M	-73.79M	-18.81%
Dec 31, 2021	392.27M	-196.83M	-33.41%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Hubei Goto Biopharm	626.28M
Guiyang Xintian Pharmaceutical	755.34M
Hunan Nucien Pharmaceutical	141.93M
Jiangsu CoWin Biotech	193.05M
Zhejiang East Asia Pharmaceutical	831.56M
Shanghai Serum Bio-Technology	196.21M
Shandong Sito Bio-technology	954.76M
Jilin Jian Yisheng Pharmaceutical	639.10M

Revenue Rankings